Badger Meter Inc
NYSE: BMI · TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS
Updated 2026-04-29
Badger Meter Inc (BMI) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for BMI.
Current price exceeds what fundamentals support. Risk/reward skewed unfavorably.
BMI historical valuation range
Where current P/E sits in BMI's own 5Y range.
BMI intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
BMI valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
Current: 26.67x
P/S Ratio — History
Current: 3.84x
Is BMI overvalued in 2026?
Badger Meter Inc (BMI) currently trades at $117.86 per share with a market capitalization of $3,439,811,000.00. Based on our multi-factor framework, the stock appears richly valued with a Smart Value Score of 46/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
The stock trades at a P/E ratio of 26.7x, below its 5-year median of 47.5x. The PEG ratio of 2.96 indicates the price has run ahead of the underlying growth rate.
Looking at its own history, BMI is currently trading cheaper than 92% of the last 5Y on P/E. This places it in the 8th percentile of its historical range, a level that has historically coincided with attractive entry points.
Our discounted cash flow model estimates BMI's intrinsic value at $138.99 per share, against the current market price of $117.86. This implies a premium to fair value of -12.90%. The current price sits well above what projected cash flows justify, implying investors are paying for growth that has not yet materialized.
Financial quality is a concern. The Piotroski F-Score of 2/9 flags weakening fundamentals that deserve closer scrutiny before the valuation case can be fully trusted.
Bottom line: BMI appears richly valued on our framework, with a Smart Value Score of 46/100. At current levels the risk/reward is skewed against the buyer. A materially lower price or significant operational improvement would be needed to change the picture.
Frequently asked questions
Is BMI overvalued in 2026?
Based on a Smart Value Score of 46/100, BMI appears overvalued. Current price exceeds what fundamentals currently justify.
What is BMI's fair value?
Our DCF model estimates BMI's intrinsic value at $138.99 per share, versus the current price of $117.86. This produces a margin of safety of -12.90%.
What P/E ratio does BMI trade at?
BMI trades at a P/E of 26.7x on trailing twelve-month earnings, compared to its 5-year median of 47.5x.
Is BMI a buy based on valuation?
WallStSmart does not issue buy or sell recommendations. Our Smart Value Score of 46/100 reflects the combined read on growth, quality, and price. The profile skews cautious. Consider waiting for a better price or clearer operational improvement.
How does BMI's valuation compare to its history?
On P/E, BMI currently sits in the 8th percentile of its own 5Y range. That is historically cheap relative to where it has traded over the period.
What is BMI's Smart Value Score?
BMI's Smart Value Score is 46/100. The Smart Value Score is a proprietary WallStSmart metric blending growth quality, financial health, and valuation attractiveness into a single 0-100 read. Scores above 75 are rare and indicate strong multi-factor alignment.